Article: Generative AI Holds the Key to Transforming Trial Design
Recent AI applications rely heavily on predictive AI, which harnesses historical data to make predictions and recommendations for the future. But what is really propelling the industry forward is generative AI, which uses models or algorithms to create various types of content using learned patterns based on the data on which it was trained.
SVP/Chief Architect Tobias Guennel outlines how generative AI will speed up clinical trial execution as sponsors integrate AI-enabled technologies into their day-to-day workflows.
Article: Women in science: Sofia Baig on breaking through the proverbial glass ceiling and strong team culture
Sofia Baig, President of Clinical Solutions at Precision, opens up about her career, the challenges she overcame, and the ways this journey shaped her as leader, a mother, and a trend setter.
Article: How to Effectively Integrate AI into Clinical Trials
As more and more healthcare researchers and clinicians adopt AI, experts have noted the impact of AI on clinical research and trial management. Precision’s Tobias Guennel sits down with PharmaNewsIntelligence to discuss AI integration, validation, and security in clinical trials.
Article: Anshul Mangal of Project Farma Discusses Policy Strategies to Address the Current Cancer Drug Shortage
In September, the American Association for Cancer Research reported that hospitals are facing the worst chemotherapy drug shortage crisis the US has ever seen. Anshul Mangal, President of Project Farma, sat down with AJMC to address the primary reasons for the current cancer drug shortages and how Project Farma is helping to address these challenges.
Article: Battling the Cancer Drug Shortage: Q&A With Anshul Mangal, President of Project Farma and Precision Advance
How can our industry address the root causes for the current cancer drug shortages, and how can we prepare and avoid these shortages? Anshul Mangal, President of Project Farma and Precision ADVANCE, sat down with PharmExec.com to share answers.